AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

Breyanzi already carries multiple oncology approvals in Europe, including in relapsed or refractory diffuse large B-cell lymphoma and high grade B ... with nasal polyps (CRSwNP), a condition ...

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

What are the rules of Quordle? Here’s the official rules description of the game: Each guess must be a valid 5 letter word. Hit the enter button to submit. After each guess, the color of the tiles ...

Welcome to GIA. Students around the globe turn to GIA for the knowledge, skills, and credentials that launch successful gem and jewelry careers. Through research, education, and unbiased gem grading ...